Gold Standard Task Force Leadership

The Gold Standard Task Force is comprised of one representative from each Gold Standard accredited organization that is also a Member in good standing of the CEO Roundtable on Cancer.

CEO Cancer Gold Standard™ Task Force Leadership

Dawn Aubel, EdD, MPH, APN-BC

Co-Chair, CEO Cancer Gold Standard™ Task Force

Director of Patient Relations in Global Development, Medical Affairs, and Breast Cancer at Novartis Oncology

Karen W. Mayer

Co-Chair, CEO Cancer Gold Standard™ Task Force

Clinical Services Support Director, Independence Blue Cross

The CEO Cancer Gold Standard™ Task Force:

Helps ensure the continued promulgation of the Gold Standard and that the program evolves in a manner that continues to foster improved health and wellness for employees and their family members
Reviews the program to ensure that it remains current with scientific evidence and applicable laws
Debates and/or recommends changes and/or enhancements to the Gold Standard requirements and/or accreditation process
Holds at least one meeting per year in addition to exchanging information within and among the Task Force through conference calls, etc.

Global CEO Cancer Gold Standard™ Task Force Leadership

Ann Skye, BSN, MPH

Subcommittee Chair, Global CEO Cancer Gold Standard™ Task Force

Associate Director, Employee Health Management, IQVIA